These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 14066175)

  • 41. Protective immunization against Treponema pallidum using specific immune complexes--an attempt.
    Engel S; Diezel W; Sönnichsen N
    Acta Derm Venereol; 1985; 65(6):484-8. PubMed ID: 2420111
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Humoral immunity in experimental syphilis. I. The demonstration of resistance conferred by passive immunization.
    Bishop NH; Miller JN
    J Immunol; 1976 Jul; 117(1):191-6. PubMed ID: 778261
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Attempts at immunization against syphilis with avirulent Treponemma pallidum.
    Izzat NN; Dacres WG; Knox JM; Wende R
    Br J Vener Dis; 1970 Dec; 46(6):451-3. PubMed ID: 4923983
    [No Abstract]   [Full Text] [Related]  

  • 44. Analysis of serum IgG against Treponema pallidum protein antigens in experimentally infected rabbits.
    Alderete JF; Baseman JB
    Br J Vener Dis; 1981 Oct; 57(5):302-8. PubMed ID: 7028207
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Notes on syphilis vaccine development.
    Kojima N; Konda KA; Klausner JD
    Front Immunol; 2022; 13():952284. PubMed ID: 35967432
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Supplementary findings on methods for the serodiagnosis of syphilis. 1. Serological specificity of the antigen of Treponema pallidum Reiter strain].
    Tomizawa T; Kasamatsu S; Yamaya S; Yamada M
    Nihon Saikingaku Zasshi; 1966 May; 21(5):251-5. PubMed ID: 5333565
    [No Abstract]   [Full Text] [Related]  

  • 47. Characterization of lymphocyte responsiveness in early experimental syphilis. I. In vitro response to mitogens and Treponema pallidum antigens.
    Lukehart SA; Baker-Zander SA; Sell S
    J Immunol; 1980 Jan; 124(1):454-60. PubMed ID: 6153102
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Passive transfer of immunity to experimental syphilis in rabbits by immune lymphocytes.
    Metzger M; Smogór W
    Arch Immunol Ther Exp (Warsz); 1975; 23(5):625-30. PubMed ID: 766726
    [No Abstract]   [Full Text] [Related]  

  • 49. Subfamily I Treponema pallidum repeat protein family: sequence variation and immunity.
    Sun ES; Molini BJ; Barrett LK; Centurion-Lara A; Lukehart SA; Van Voorhis WC
    Microbes Infect; 2004 Jul; 6(8):725-37. PubMed ID: 15207819
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The rate of multiplication of Treponema pallidum in normal and immune rabbits.
    CUMBERLAND MC; TURNER TB
    Am J Syph Gonorrhea Vener Dis; 1949 May; 33(3):201-12. PubMed ID: 18121293
    [No Abstract]   [Full Text] [Related]  

  • 51. Enhanced immune response and protective efficacy of a Treponema pallidum Tp92 DNA vaccine vectored by chitosan nanoparticles and adjuvanted with IL-2.
    Zhao F; Wu Y; Zhang X; Yu J; Gu W; Liu S; Zeng T; Zhang Y; Wang S
    Hum Vaccin; 2011 Oct; 7(10):1083-9. PubMed ID: 21941092
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Susceptibility of rabbits to Treponema pallidum after infection with Mycobacterium bovis.
    Graves S
    Br J Vener Dis; 1979 Dec; 55(6):394-8. PubMed ID: 393361
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [PRESENCE AND PERSISTENCE OF TREPONEMAS IN THE CEREBROSPINAL FLUID IN THE COURSE OF EXPERIMENTAL AND HUMAN SYPHILIS FOLLOWING DELAYED TREATMENT].
    COLLART P; DUREL P
    Ann Dermatol Syphiligr (Paris); 1964; 91():485-98. PubMed ID: 14237500
    [No Abstract]   [Full Text] [Related]  

  • 54. Production of immobilizing antibodies unaccompanied by active immunity to Treponema pallidum as shown by injecting rabbits and mice with the killed organisms.
    MCLEOD CP; MAGNUSON HJ
    Am J Syph Gonorrhea Vener Dis; 1953 Jan; 37(1):9-22. PubMed ID: 13016902
    [No Abstract]   [Full Text] [Related]  

  • 55. Use of the skin protection assay in experimental syphilis to assess protective immunity against a specific Treponema pallidum surface epitope.
    Blanco DR; Champion CI; Lovett MA
    FEMS Microbiol Lett; 2005 Aug; 249(1):171-5. PubMed ID: 16000244
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of humoral versus cellular mechanisms of resistance in the pathogenesis of syphilis.
    Metzger M
    Br J Vener Dis; 1979 Apr; 55(2):94-8. PubMed ID: 376063
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reiter treponeme. A review of the literature.
    Wallce AL; Harris A; Allen JP
    Bull World Health Organ; 1967; 36 Suppl(1):1-103. PubMed ID: 4865377
    [No Abstract]   [Full Text] [Related]  

  • 58. Opsonic potential, protective capacity, and sequence conservation of the Treponema pallidum subspecies pallidum Tp92.
    Cameron CE; Lukehart SA; Castro C; Molini B; Godornes C; Van Voorhis WC
    J Infect Dis; 2000 Apr; 181(4):1401-13. PubMed ID: 10762571
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [STUDIES ON LATE SYPHILIS. PERSISTENCE OF TREPONEMA PALLIDUM FOLLOWING PENICILLIN THERAPY IN EXPERIMENTAL AND HUMAN SYPHILIS].
    COLLART P; BOREL LJ; DUREL P
    Clinique (Paris); 1964 Nov; 59():653-7. PubMed ID: 14243934
    [No Abstract]   [Full Text] [Related]  

  • 60. Circulating immune complexes in experimental syphilis and their relation to immunological response against Treponema pallidum.
    Podwińska J
    FEMS Microbiol Immunol; 1991 Apr; 3(2):83-91. PubMed ID: 1863472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.